SCHEMBL8511633

SCHEMBL8511633

O=C(O)c1nc(Cl)cc(Cl)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.48
AKR1C2 P52895 2/20 0.44
AKR1C1 Q04828 2/20 0.44
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RNASEH1 O60930 1/20 0.40
KMO O15229 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
LMNA P02545 1/20 0.39
GRIK1 P39086 1/20 0.39
GRIA1 P42261 1/20 0.39
GRIA2 P42262 1/20 0.39
GRIA3 P42263 1/20 0.39
GRIA4 P48058 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIK2 Q13002 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347014 0.81 TDP1 (0.44) TTRMEN1KMT2ARNASEH1GRIN2D
SCHEMBL19627732 0.80 TDP1 (0.40) TTRAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL21120426 0.79 ALDH1A1 (0.46) TTRMEN1KMT2AKMOGRIN2D
SCHEMBL14768691 0.78 MEN1 (0.40) MEN1KMT2AKMOGRIN2DGRIN3B
SCHEMBL536122 0.78 TDP1 (0.46) TTRMEN1KMT2AKMOGRIN2D
SCHEMBL19283132 0.76 PKM (0.50) MEN1KMT2ARNASEH1LMNAALDH1A1
SCHEMBL14354477 0.73 TPMT (0.49) MEN1KMT2AKMOLMNAALDH1A1
SCHEMBL31071679 0.72 MEN1 (0.42) TTRAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL2224615 0.72 MEN1 (0.42) TTRAKR1C2AKR1C1AKR1C4AKR1C3
Clopyralid SCHEMBL29371357 0.71 KMT2A (0.50) MEN1KMT2AALDH1A1DPP4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643312-B1 MICROBICIDAL HETEROCYCLES SYNGENTA PARTICIPATIONS AG (CH) 2014-09-10 EP disclosed
US-8748431-B2 Microbicidal heterocycles SYNGENTA PARTICIPATIONS AG (CH) 2014-06-10 US disclosed
US-20130324544-A1 MICROBICIDAL HETEROCYCLES SYNGENTA PARTICIPATIONS AG (CH) 2013-12-05 US disclosed
EP-2643312-A1 MICROBICIDAL HETEROCYCLES Syngenta Participations AG (CH) 2013-10-02 EP disclosed
WO-2012069633-A1 MICROBICIDAL HETEROCYCLES SYNGENTA PARTICIPATIONS AG (CH) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130324544-A1 MICROBICIDAL HETEROCYCLES CYP1A1, CYP1B1, CYP51A1 TTR 3468/4885AKR1C2 1038/4885AKR1C1 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.